# Investment Committee Memo

**Fund/Opportunity:** [Name]
**Prepared by:** [Analyst Name]
**Date:** [Date]
**IC Meeting:** [Scheduled Date]
**Recommendation:** [Approve / Reject / Further Review]
**Conviction Level:** [High / Medium / Low]

*AI-Assisted Draft — Analyst Review Required Before IC Submission*

---

## Executive Summary
[3-5 sentences: What is the opportunity, why are we looking at it, what's the recommendation, and what's the key risk. Be specific — avoid generic language.]

---

## Investment Thesis

### Opportunity Overview
| | Details |
|---|---|
| **Fund/Manager** | [Name] |
| **Strategy** | [Strategy description] |
| **AUM** | [Fund AUM] |
| **Vintage/Inception** | [Date] |
| **Target Return** | [X% net IRR / X% annual] |
| **Fee Structure** | [Management fee + performance fee] |
| **Liquidity** | [Lock-up period, redemption terms] |
| **Minimum Investment** | [Amount] |
| **Domicile/Jurisdiction** | [Where the fund is domiciled] |

### Why This Opportunity
1. [Key thesis point 1 — why this is attractive]
2. [Key thesis point 2 — differentiation or edge]
3. [Key thesis point 3 — market timing or structural advantage]

### Conviction Challenge: What Could Make This Thesis Wrong?
[This section is mandatory. For every thesis, explicitly state the bear case.]

1. [Scenario where the investment underperforms — what market condition, manager action, or structural change would break the thesis?]
2. [Second failure scenario — different from the first]
3. [Third failure scenario — what would make you reverse the recommendation?]

**Conditions for Thesis Reassessment:**
- [Trigger 1: e.g., "If manager AUM exceeds $X, revisit capacity constraints"]
- [Trigger 2: e.g., "If key person departs, immediate review required"]
- [Trigger 3: e.g., "If trailing 12-month performance drops below benchmark by X%, reassess"]

### Manager Assessment
| Criterion | Rating (1-5) | Notes |
|---|---|---|
| Track record | | |
| Team stability & depth | | |
| Investment process rigor | | |
| Risk management framework | | |
| Operational infrastructure | | |
| Transparency & reporting | | |
| Alignment of interests (co-investment, fee structure) | | |

---

## Peer Comparison

| Metric | **[This Fund]** | [Peer 1] | [Peer 2] | [Peer 3] | [Peer 4] | [Peer 5] |
|---|---|---|---|---|---|---|
| Strategy | | | | | | |
| AUM | | | | | | |
| Inception | | | | | | |
| 3-Year Return (ann.) | | | | | | |
| 5-Year Return (ann.) | | | | | | |
| Volatility (ann.) | | | | | | |
| Sharpe Ratio | | | | | | |
| Max Drawdown | | | | | | |
| Management Fee | | | | | | |
| Performance Fee | | | | | | |
| Liquidity Terms | | | | | | |

**Why this fund over peers:** [2-3 sentences on differentiation]

---

## Performance Analysis

### Historical Returns
| Period | Fund | Benchmark | Alpha | Peer Median |
|---|---|---|---|---|
| 1 Year | | | | |
| 3 Year (ann.) | | | | |
| 5 Year (ann.) | | | | |
| Since Inception (ann.) | | | | |

### Risk Metrics
| Metric | Value | Peer Median | Comment |
|---|---|---|---|
| Volatility (ann.) | | | |
| Sharpe Ratio | | | |
| Max Drawdown | | | |
| Sortino Ratio | | | |

### Concentration Analysis
| Metric | Value | Comment |
|---|---|---|
| Number of positions | | |
| Top 5 positions (% of portfolio) | | [Flag if >50%] |
| Top 10 positions (% of portfolio) | | |
| % of returns from top 2 positions (trailing 12mo) | | [Flag if >40%] |
| Largest single position | | [Flag if >15%] |

**Concentration Risk Assessment:** [Is the fund overly concentrated? What happens if the top holding drops 30%? Is concentration a feature of the strategy or a concern?]

---

## Risk Assessment

### Key Risks
| Risk | Severity | Likelihood | Mitigation | Base Rate |
|---|---|---|---|---|
| [Market risk] | High/Med/Low | High/Med/Low | [How mitigated] | [Historical frequency of this risk materializing] |
| [Liquidity risk] | | | | |
| [Manager/key person risk] | | | | |
| [Operational risk] | | | | |
| [Regulatory risk] | | | | |
| [Concentration risk] | | | | |

### Base-Rate Assessment
[What is the historical probability of funds in this strategy/vintage delivering the target return? What % of comparable funds have underperformed their benchmark over a similar time horizon? This grounds the recommendation in historical reality rather than narrative optimism.]

### Red Flags / Concerns
- [Any concerns identified during due diligence]

*All regulatory citations in this memo require independent verification.*

---

## Fit Assessment

### Portfolio Fit
- **Which client profiles:** [Which risk profiles / strategies does this suit?]
- **Allocation size:** [Recommended allocation as % of portfolio]
- **Diversification benefit:** [How does this complement existing holdings?]
- **Overlap analysis:** [Does this duplicate exposure we already have?]

### Suitability
- [ ] Suitable for Conservative profiles
- [ ] Suitable for Balanced profiles
- [ ] Suitable for Growth profiles
- [ ] Suitable for Aggressive profiles
- [ ] MiFID II suitability requirements reviewed
- [ ] Sharia-compliant (if applicable)
- [ ] ESG criteria met (if applicable)

---

## Due Diligence Checklist
- [ ] Manager meeting conducted
- [ ] Reference checks completed (min. 3 references)
- [ ] Operational due diligence reviewed
- [ ] Legal documentation reviewed
- [ ] Compliance sign-off obtained
- [ ] Fee analysis completed (all-in cost vs. peers)
- [ ] Peer comparison conducted (min. 5 peers)
- [ ] Concentration risk analyzed
- [ ] Liquidity stress test reviewed
- [ ] Regulatory status verified (manager's registration and compliance history)

---

## Recommendation
[Clear recommendation with reasoning. If recommending approval, specify conditions. If rejecting, explain what would need to change. Frame recommendation relative to the conviction challenge — why does the bull case outweigh the bear case?]

### Conditions (if Approve)
1. [Any conditions for approval]

### Monitoring Triggers
1. [When should this investment be formally reassessed?]
2. [What performance or market triggers would require an ad-hoc review?]

### Next Steps
1. [Immediate action items]

---

**Compliance Review:** Pending Compliance Review
**Compliance Officer:** [Name and date — must be manually completed]

---

*Claudius Capital — Internal use only. Confidential.*
*Memo generated: [timestamp] | Memo ID: [unique ID for audit trail]*
